ProQR Therapeutics N.V (PRQR) Operating Leases: 2021-2025
Historic Operating Leases for ProQR Therapeutics N.V (PRQR) over the last 5 years, with Sep 2025 value amounting to -$1.5 million.
- ProQR Therapeutics N.V's Operating Leases fell 4.45% to -$1.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.5 million, marking a year-over-year decrease of 4.45%. This contributed to the annual value of $11.8 million for FY2024, which is 20.94% down from last year.
- ProQR Therapeutics N.V's Operating Leases amounted to -$1.5 million in Q3 2025, which was down 56.60% from -$973,485 recorded in Q2 2025.
- In the past 5 years, ProQR Therapeutics N.V's Operating Leases registered a high of $16.9 million during Q4 2021, and its lowest value of -$1.5 million during Q3 2025.
- Moreover, its 3-year median value for Operating Leases was -$942,277 (2024), whereas its average is $1.6 million.
- Its Operating Leases has fluctuated over the past 5 years, first plummeted by 230.68% in 2022, then spiked by 57.00% in 2023.
- ProQR Therapeutics N.V's Operating Leases (Quarterly) stood at $16.9 million in 2021, then declined by 16.47% to $14.1 million in 2022, then grew by 5.57% to $14.9 million in 2023, then dropped by 20.51% to $11.8 million in 2024, then decreased by 4.45% to -$1.5 million in 2025.
- Its Operating Leases stands at -$1.5 million for Q3 2025, versus -$973,485 for Q2 2025 and -$596,418 for Q1 2025.